- Treatment for amphetamine dependence and abuse
- Treatment for amphetamine psychosis
- Treatment for IgG and IgA paraproteinaemic neuropathy
- Treatment for Lambert‐Eaton myasthenic syndrome
- Treatment for superficial thrombophlebitis of the leg
- Tricyclic and related drugs for nocturnal enuresis in children
- Tricyclic drugs for depression in children and adolescents
- Trifluoperazine for schizophrenia
- Troleandomycin as an oral corticosteroid sparing agent in stable asthma
- Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis
- Valproate for schizophrenia
- Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
- Vancomycin for prophylaxis against sepsis in preterm neonates
- Vasoactive drugs for acute stroke
- Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss
- Vasodilators for primary Raynaud's phenomenon
- Vitamin D and vitamin D analogues for preventing fractures in post‐menopausal women and older men
- Vitamin E for Alzheimer's dementia and mild cognitive impairment
- Vitamin E for antipsychotic‐induced tardive dyskinesia
- Vitamin E for intermittent claudication
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.